[
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683076",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683076,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15098242",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15098242,
          "resourceId": "27997040",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Müller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 12,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/27997040",
          "type": "article",
          "year": 2016
        },
        {
          "@id": "https://pharmgkb.org/literature/15051926",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15051926,
          "resourceId": "23486447",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Müller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 1,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23486447",
          "type": "article",
          "year": 2013
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166105006",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105006",
          "name": "Annotation of CPIC Guideline for amitriptyline and CYP2C19,CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166105007",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105007",
          "name": "Annotation of CPIC Guideline for clomipramine and CYP2C19,CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166105002",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105002",
          "name": "Annotation of CPIC Guideline for desipramine and CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166105000",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105000",
          "name": "Annotation of CPIC Guideline for doxepin and CYP2C19,CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166104999",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104999",
          "name": "Annotation of CPIC Guideline for imipramine and CYP2C19,CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166104998",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104998",
          "name": "Annotation of CPIC Guideline for nortriptyline and CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166105001",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105001",
          "name": "Annotation of CPIC Guideline for trimipramine and CYP2C19,CYP2D6"
        }
      ],
      "text": "CPIC TCAs guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "http://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
      "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683077",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683077,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15077441",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15077441,
          "resourceId": "24918167",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 6,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/24918167",
          "type": "article",
          "year": 2014
        },
        {
          "@id": "https://pharmgkb.org/literature/15013653",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15013653,
          "resourceId": "22617227",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 5,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/22617227",
          "type": "article",
          "year": 2012
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166105005",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105005",
          "name": "Annotation of CPIC Guideline for simvastatin and SLCO1B1"
        }
      ],
      "text": "CPIC simvastatin guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-simvastatin-and-slco1b1/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184654033",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184654033,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15080841",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15080841,
          "resourceId": "25099164",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing",
          "authors": [
            "Caudle Kelly E",
            "Rettie Allan E",
            "Whirl-Carrillo Michelle",
            "Smith Lisa H",
            "Mintzer Scott E",
            "Lee Ming Ta Michael",
            "Klein Teri E",
            "Callaghan J Thomas"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 8,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/25099164",
          "type": "article",
          "year": 2014
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166122806",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166122806",
          "name": "Annotation of CPIC Guideline for phenytoin and CYP2C9,HLA-B"
        }
      ],
      "text": "CPIC phenytoin guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683078",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683078,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15058235",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15058235,
          "resourceId": "23698643",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update",
          "authors": [
            "Scott Stuart A",
            "Sangkuhl Katrin",
            "Stein C Michael",
            "Hulot Jean-Sébastien",
            "Mega Jessica L",
            "Roden Dan M",
            "Klein Teri E",
            "Sabatine Marc S",
            "Johnson Julie A",
            "Shuldiner Alan R"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 5,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23698643",
          "type": "article",
          "year": 2013
        },
        {
          "@id": "https://pharmgkb.org/literature/8231172",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 8231172,
          "resourceId": "21716271",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy",
          "authors": [
            "Scott S A",
            "Sangkuhl K",
            "Gardner E E",
            "Stein C M",
            "Hulot J-S",
            "Johnson J A",
            "Roden D M",
            "Klein T E",
            "Shuldiner A R"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 6,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21716271",
          "type": "article",
          "year": 2011
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166104948",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104948",
          "name": "Annotation of CPIC Guideline for clopidogrel and CYP2C19"
        }
      ],
      "text": "CPIC clopidogrel guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683079",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683079,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15098503",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15098503,
          "resourceId": "28198005",
          "title": "Clinical pharmacogenetics implementation consortium (cpic) guideline for pharmacogenetics-guided warfarin dosing: 2017 update",
          "authors": [
            "Johnson Julie A",
            "Caudle Kelly E",
            "Gong Li",
            "Whirl-Carrillo Michelle",
            "Stein C Michael",
            "Scott Stuart A",
            "Lee Ming Ta Michael",
            "Gage Brian F",
            "Kimmel Stephen E",
            "Perera Minoli A",
            "Anderson Jeffrey L",
            "Pirmohamed Munir",
            "Klein Teri E",
            "Limdi Nita A",
            "Cavallari Larisa H",
            "Wadelius Mia"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 2,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/28198005",
          "type": "article",
          "year": 2017
        },
        {
          "@id": "https://pharmgkb.org/literature/8560040",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 8560040,
          "resourceId": "21900891",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing",
          "authors": [
            "Johnson J A",
            "Gong L",
            "Whirl-Carrillo M",
            "Gage B F",
            "Scott S A",
            "Stein C M",
            "Anderson J L",
            "Kimmel S E",
            "Lee M T M",
            "Pirmohamed M",
            "Wadelius M",
            "Klein T E",
            "Altman R B"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 9,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21900891",
          "type": "article",
          "year": 2011
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166104949",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104949",
          "name": "Annotation of CPIC Guideline for warfarin and CYP2C9,CYP4F2,VKORC1"
        }
      ],
      "text": "CPIC warfarin guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683080",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683080,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15099812",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15099812,
          "resourceId": "29152729",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update",
          "authors": [
            "Amstutz Ursula",
            "Henricks Linda M",
            "Offer Steven M",
            "Barbarino Julia",
            "Schellens Jan H M",
            "Swen Jesse J",
            "Klein Teri E",
            "McLeod Howard L",
            "Caudle Kelly E",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 11,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/29152729",
          "type": "article",
          "year": 2017
        },
        {
          "@id": "https://pharmgkb.org/literature/15062135",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15062135,
          "resourceId": "23988873",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing",
          "authors": [
            "Caudle Kelly E",
            "Thorn Caroline F",
            "Klein Teri E",
            "Swen Jesse J",
            "McLeod Howard L",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 8,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23988873",
          "type": "article",
          "year": 2013
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166109594",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166109594",
          "name": "Annotation of CPIC Guideline for capecitabine and DPYD"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166122686",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166122686",
          "name": "Annotation of CPIC Guideline for fluorouracil and DPYD"
        }
      ],
      "text": "CPIC fluoropyrimidine guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683081",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683081,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15070904",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15070904,
          "resourceId": "24561393",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update",
          "authors": [
            "Martin Michael A",
            "Hoffman James M",
            "Freimuth Robert R",
            "Klein Teri E",
            "Dong Betty J",
            "Pirmohamed Munir",
            "Hicks J Kevin",
            "Wilkinson Mark R",
            "Haas David W",
            "Kroetz Deanna L"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 2,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/24561393",
          "type": "article",
          "year": 2014
        },
        {
          "@id": "https://pharmgkb.org/literature/14962778",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 14962778,
          "resourceId": "22378157",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing",
          "authors": [
            "Martin M A",
            "Klein T E",
            "Dong B J",
            "Pirmohamed M",
            "Haas D W",
            "Kroetz D L"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 2,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/22378157",
          "type": "article",
          "year": 2012
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166104997",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104997",
          "name": "Annotation of CPIC Guideline for abacavir and HLA-B"
        }
      ],
      "text": "CPIC abacavir guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-abacavir-and-hla-b/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683082",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683082,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15058356",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15058356,
          "resourceId": "23695185",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing",
          "authors": [
            "Leckband Susan G",
            "Kelsoe John R",
            "Dunnenberger H Mark",
            "George Alfred L",
            "Tran Eric",
            "Berger Reisel",
            "Müller Daniel J",
            "Whirl-Carrillo Michelle",
            "Caudle Kelly E",
            "Pirmohamed Munir"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 5,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23695185",
          "type": "article",
          "year": 2013
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166105008",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105008",
          "name": "Annotation of CPIC Guideline for carbamazepine and HLA-A,HLA-B"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166176623",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166176623",
          "name": "Annotation of CPIC Guideline for oxcarbazepine and HLA-B"
        }
      ],
      "text": "CPIC carbamazepine guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/content/guideline/publication/carbamazepine/2017/CPIC_HLA_CBZ_OXC_submitted_version.pdf",
      "https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683083",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683083,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15090607",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15090607,
          "resourceId": "26094938",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update",
          "authors": [
            "Saito Y",
            "Stamp L K",
            "Caudle K E",
            "Hershfield M S",
            "McDonagh E M",
            "Callaghan J T",
            "Tassaneeyakul W",
            "Mushiroda T",
            "Kamatani N",
            "Goldspiel B R",
            "Phillips E J",
            "Klein T E",
            "Lee Mtm"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 6,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/26094938",
          "type": "article",
          "year": 2015
        },
        {
          "@id": "https://pharmgkb.org/literature/15033427",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15033427,
          "resourceId": "23232549",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing",
          "authors": [
            "Hershfield M S",
            "Callaghan J T",
            "Tassaneeyakul W",
            "Mushiroda T",
            "Thorn C F",
            "Klein T E",
            "Lee M T M"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 10,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23232549",
          "type": "article",
          "year": 2012
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166105003",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166105003",
          "name": "Annotation of CPIC Guideline for allopurinol and HLA-B"
        }
      ],
      "text": "CPIC allopurinol guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-allopurinol-and-hla-b/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683084",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683084,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15051187",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15051187,
          "resourceId": "23422873",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 1,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23422873",
          "type": "article",
          "year": 2013
        },
        {
          "@id": "https://pharmgkb.org/literature/6690400",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 6690400,
          "resourceId": "21270794",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 3,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21270794",
          "type": "article",
          "year": 2011
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166104933",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104933",
          "name": "Annotation of CPIC Guideline for azathioprine and TPMT"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166104945",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104945",
          "name": "Annotation of CPIC Guideline for mercaptopurine and TPMT"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166104965",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104965",
          "name": "Annotation of CPIC Guideline for thioguanine and TPMT"
        }
      ],
      "text": "CPIC thiopurine guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683072",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683072,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15069654",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15069654,
          "resourceId": "24458010",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 1,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/24458010",
          "type": "article",
          "year": 2014
        },
        {
          "@id": "https://pharmgkb.org/literature/14821790",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 14821790,
          "resourceId": "22205192",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 12,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/22205192",
          "type": "article",
          "year": 2011
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166104996",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166104996",
          "name": "Annotation of CPIC Guideline for codeine and CYP2D6"
        }
      ],
      "text": "CPIC codeine guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683073",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683073,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15064565",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15064565,
          "resourceId": "24096968",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens",
          "authors": [
            "Muir Andrew J",
            "Gong Li",
            "Johnson Samuel G",
            "Michael Lee Ming Ta",
            "Williams Marc S",
            "Klein Teri E",
            "Caudle Kelly E",
            "Nelson David R"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 10,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/24096968",
          "type": "article",
          "year": 2013
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166110235",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166110235",
          "name": "Annotation of CPIC Guideline for peginterferon alfa-2a,peginterferon alfa-2b,ribavirin and IFNL3"
        }
      ],
      "text": "CPIC PEG interferon-alpha guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683074",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683074,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15071319",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15071319,
          "resourceId": "24598717",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype",
          "authors": [
            "Clancy John P",
            "Johnson Samuel G",
            "Yee Sook Wah",
            "McDonagh Ellen M",
            "Caudle Kelly E",
            "Klein Teri E",
            "Cannavo Matthew",
            "Giacomini Kathleen M"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 3,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/24598717",
          "type": "article",
          "year": 2014
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166114461",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166114461",
          "name": "Annotation of CPIC Guideline for ivacaftor and CFTR"
        }
      ],
      "text": "CPIC ivacaftor guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1184683075",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1184683075,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15074661",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15074661,
          "resourceId": "24787449",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the context of G6PD Deficiency Genotype",
          "authors": [
            "Relling Mary V",
            "McDonagh Ellen M",
            "Chang Tamara",
            "Caudle Kelly E",
            "McLeod Howard L",
            "Haidar Cyrine E",
            "Klein Teri",
            "Luzzatto Lucio"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 5,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/24787449",
          "type": "article",
          "year": 2014
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166119846",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166119846",
          "name": "Annotation of CPIC Guideline for rasburicase and G6PD"
        }
      ],
      "text": "CPIC rasburicase guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-rasburicase-and-g6pd/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1449154368",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1449154368,
      "history": [
        {
          "id": 1449154369,
          "date": "2017-11-21T16:15:33.120-08:00",
          "description": "created",
          "type": "create",
          "version": 0
        }
      ],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15062135",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15062135,
          "resourceId": "23988873",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing",
          "authors": [
            "Caudle Kelly E",
            "Thorn Caroline F",
            "Klein Teri E",
            "Swen Jesse J",
            "McLeod Howard L",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 8,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/23988873",
          "type": "article",
          "year": 2013
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166122687",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166122687",
          "name": "Annotation of CPIC Guideline for tegafur and DPYD"
        }
      ],
      "text": "CPIC tegafur guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1444699035",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1444699035,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15087045",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15087045,
          "resourceId": "25801146",
          "title": "Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing",
          "authors": [
            "Birdwell Kelly A",
            "Decker Brian",
            "Barbarino Julia M",
            "Peterson Josh F",
            "Stein C Michael",
            "Sadee Wolfgang",
            "Wang Danxin",
            "Vinks Alexander A",
            "He Yijing",
            "Swen Jesse J",
            "Leeder J Steven",
            "van Schaik R H N",
            "Thummel Kenneth E",
            "Klein Teri E",
            "Caudle Kelly E",
            "MacPhee Iain A M"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 3,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/25801146",
          "type": "article",
          "year": 2015
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166124619",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166124619",
          "name": "Annotation of CPIC Guideline for tacrolimus and CYP3A5"
        }
      ],
      "text": "CPIC tacrolimus guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1446902988",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1446902988,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15093021",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15093021,
          "resourceId": "26417955",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing",
          "authors": [
            "Gammal Roseann S",
            "Court Michael H",
            "Haidar Cyrine E",
            "Iwuchukwu Otito Frances",
            "Gaur Aditya H",
            "Alvarellos Maria",
            "Guillemette Chantal",
            "Lennox Jeffrey L",
            "Whirl-Carrillo Michelle",
            "Brummel Sean",
            "Ratain Mark J",
            "Klein Teri E",
            "Schackman Bruce R",
            "Caudle Kelly E",
            "Haas David W"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 9,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/26417955",
          "type": "article",
          "year": 2015
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166128738",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166128738",
          "name": "Annotation of CPIC Guideline for atazanavir and UGT1A1"
        }
      ],
      "text": "CPIC atazanavir guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1444709215",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1444709215,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15089021",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15089021,
          "resourceId": "25974703",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Müller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena Adrián",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 5,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/25974703",
          "type": "article",
          "year": 2015
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166127638",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166127638",
          "name": "Annotation of CPIC Guideline for citalopram,escitalopram and CYP2C19"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166127637",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166127637",
          "name": "Annotation of CPIC Guideline for fluvoxamine and CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166127636",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166127636",
          "name": "Annotation of CPIC Guideline for paroxetine and CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166127639",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166127639",
          "name": "Annotation of CPIC Guideline for sertraline and CYP2C19"
        }
      ],
      "text": "CPIC SSRIs guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1448530669",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1448530669,
      "history": [],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15098243",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15098243,
          "resourceId": "27981572",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy",
          "authors": [
            "Moriyama Brad",
            "Obeng Aniwaa Owusu",
            "Barbarino Julia",
            "Penzak Scott R",
            "Henning Stacey A",
            "Scott Stuart A",
            "Agúndez José A G",
            "Wingard John R",
            "McLeod Howard L",
            "Klein Teri E",
            "Cross Shane",
            "Caudle Kelly E",
            "Walsh Thomas J"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 12,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/27981572",
          "type": "article",
          "year": 2016
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166161537",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166161537",
          "name": "Annotation of CPIC Guideline for voriconazole and CYP2C19"
        }
      ],
      "text": "CPIC voriconazole guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/"
    ]
  },
  {
    "publicationSet": {
      "@id": "https://pharmgkb.org/dataAnnotation/1448573557",
      "@context": "https://api.pharmgkb.org/jsonld/dataAnnotation.jsonld",
      "id": 1448573557,
      "history": [
        {
          "id": 1448573558,
          "date": "2017-02-01T13:07:05.914-08:00",
          "description": "created",
          "type": "create",
          "version": 0
        }
      ],
      "literature": [
        {
          "@id": "https://pharmgkb.org/literature/15098241",
          "@context": "https://api.pharmgkb.org/jsonld/literature.jsonld",
          "id": 15098241,
          "resourceId": "28002639",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron",
          "authors": [
            "Bell Gillian C",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Gordon Ronald J",
            "Hikino Keiko",
            "Prows Cynthia A",
            "Gaedigk Andrea",
            "Agundez Jose A G",
            "Sadhasivam Senthilkumar",
            "Klein Teri E",
            "Schwab Matthias"
          ],
          "journal": "Clinical pharmacology and therapeutics",
          "month": 12,
          "sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/28002639",
          "type": "article",
          "year": 2016
        }
      ],
      "sources": [
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "targets": [
        {
          "@id": "https://pharmgkb.org/guideline/PA166161954",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166161954",
          "name": "Annotation of CPIC Guideline for ondansetron and CYP2D6"
        },
        {
          "@id": "https://pharmgkb.org/guideline/PA166161955",
          "@context": "https://api.pharmgkb.org/jsonld/guideline.jsonld",
          "objCls": "Guideline",
          "id": "PA166161955",
          "name": "Annotation of CPIC Guideline for tropisetron and CYP2D6"
        }
      ],
      "text": "CPIC Ondansetron Guideline",
      "type": "publicationSet"
    },
    "guidelinePages": [
      "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/"
    ]
  }
]
